Dr Su Yin Lim
Improving Current Melanoma Therapies
Esther’s research looks for ways to boost the human immune system to improve the effectiveness of current melanoma therapies.
Specifically, she investigates inhibitors for a protein pathway in the body known as MAPK, which plays a key role in the development of melanoma.
Work in this field has already improved survival rates of the 30-40% of Australian patients who have a form of the disease known as BRAF-mutant melanoma.
“Outcomes of this project will translate rapidly into clinical practice, and will hopefully help improve patients’ lives,” she says.